Unlabelled: Intravascular delivery of an E1/E3 deleted adenovirus encoding the hirudin protein reduces neointimal formation in the rat arterial injury model. Given the interspecies variability in response to adenoviral vectors, we tested this same construct in the hirudin-sensitive cholesterol-fed rabbit arterial balloon injury model. We hypothesized that local delivery of an E1/E3-deleted adenovirus encoding hirudin (Ad-Hir) in addition to early hirudin infusion would limit neointimal formation compared to early hirudin alone.

Methods And Results: Local delivery of Ad-Hir, 2.5 x 10(10) PFU/ml, using a double balloon catheter [n = 6 vessels (v)] produced a 79% reduction in vessel wall thrombin activity at 48 h after balloon angioplasty (BA) compared with vehicle (Veh, n = 6v; p = 0. 05). In chronic experiments, hypercholesterolemic rabbits underwent femoral BA, and received either early hirudin alone (n = 9v) or early hirudin plus locally delivered Ad-Hir (early hirudin + Ad-Hir; n = 9v), an E1/E3-deleted adenovirus encoding beta-galactosidase (early hirudin + AdGal; n = 7v), or Veh (early hirudin + Veh; n = 10v). Early hirudin + Ad-Hir did not limit the arterial response to injury versus the other groups at 4 weeks after BA. Plaque area, cross-sectional luminal area narrowing by plaque, and T cell infiltration were significantly increased in the adenovirus- versus non-adenovirus-treated arteries. Plaque area correlated with T cell density.

Conclusion: Following BA in cholesterol-fed rabbits, local transduction with A-Hir produced a marked reduction in vessel wall-associated thrombin activity. However, this strategy increased rather than decreased the arterial response to BA injury. Our results suggest that the lack of therapeutic effect resulted from adenovirus-stimulated plaque formation, possibly resulting from a T cell-mediated inflammatory response.

Download full-text PDF

Source
http://dx.doi.org/10.1159/000025672DOI Listing

Publication Analysis

Top Keywords

early hirudin
32
injury model
12
adenovirus encoding
12
hirudin ad-hir
12
hirudin
11
rabbit arterial
8
arterial injury
8
encoding hirudin
8
neointimal formation
8
local delivery
8

Similar Publications

Medicinal leeches of the genus Hirudo inhabit large areas of the Palaearctic realm. The distribution range of Hirudo troctina includes the southern Iberian peninsula and the northwestern regions of Africa. H.

View Article and Find Full Text PDF
Article Synopsis
  • * One of the complications that can arise after surgery is venous congestion, which might lead to losing the reconstructed flap, and addressing this issue often requires additional surgical intervention.
  • * This text discusses the use of the anticoagulant bivalirudin, a drug that has recently gained attention in treating venous congestion, based on a series of cases involving 7 patients treated by the authors' team.
View Article and Find Full Text PDF

Background: In the early stages of diabetic kidney disease (DKD), the pathogenesis involves abnormal angiogenesis in the glomerulus. Hirudin, as a natural specific inhibitor of thrombin, has been shown in previous studies to inhibit the migration of various tumor endothelial cells and abnormal angiogenesis. However, its role in DKD remains unclear.

View Article and Find Full Text PDF

Background: Drug Reaction with Eosinophilia and Systemic Symptoms (DRESS) Syndrome is a severe adverse drug reaction marked by delayed hypersensitivity reactions causing skin and systemic complications. DRESS diagnosis is challenging due to the variety of clinical presentations and symptom overlap with other conditions. The perioperative period in these patients requires precise pharmacological strategies to prevent complications associated with this syndrome.

View Article and Find Full Text PDF
Article Synopsis
  • The study aims to compare the effectiveness and safety of bivalirudin versus heparin in patients with non-ST-segment-elevation myocardial infarction (NSTEMI) undergoing percutaneous coronary intervention (PCI), as previous analyses lacked detailed data.
  • An individual patient data meta-analysis included over 12,000 patients from five major trials, focusing on outcomes like 30-day all-cause mortality and serious bleeding.
  • Results indicated no significant difference in 30-day mortality rates, cardiac mortality, reinfarction, or stent thrombosis between bivalirudin and heparin in this patient population.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!